Aspirin Use for Preeclampsia Prevention Among Women With Prepregnancy Diabetes, Obesity, and Hypertension

Joel G Ray; Kasim E Abdulaziz; Howard Berger; DOH-NET (Diabetes, Obesity, and Hypertension in Pregnancy Research Network)

doi:10.1001/jama.2021.22749

Aspirin Use for Preeclampsia Prevention Among Women With Prepregnancy Diabetes, Obesity, and Hypertension

JAMA. 2022 Jan 25;327(4):388-390. doi: 10.1001/jama.2021.22749.

Authors

Joel G Ray¹, Kasim E Abdulaziz², Howard Berger³; DOH-NET (Diabetes, Obesity, and Hypertension in Pregnancy Research Network)

Affiliations

¹ Department of Medicine, St Michael's Hospital, Toronto, Ontario, Canada.
² Better Outcomes Registry and Network Ontario, Ottawa, Canada.
³ Department of Obstetrics and Gynaecology, St Michael's Hospital, Toronto, Ontario, Canada.

Abstract

This study estimates aspirin use for preeclampsia prevention in pregnant women with prepregnancy diabetes, obesity, chronic hypertension, and combinations of these factors in 2018-2020.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Aspirin / therapeutic use*
Female
Humans
Hypertension*
Length of Stay
Obesity*
Pre-Eclampsia / prevention & control*
Pregnancy
Pregnancy Complications / drug therapy*
Pregnancy in Diabetics*
Premature Birth / epidemiology

Substances

Aspirin